Bio-Rad Laboratories Total Current Liabilities

Bio-Rad Laboratories (BIO) currently reports a total current liabilities of $920M as of March 2026. That compares with $510M in the prior-year period — up 81.0% year over year. Use the charts on this page to explore Bio-Rad Laboratories's total current liabilities history and peer comparisons.

Bio-Rad Laboratories's total current liabilities increased from $510M to $920M — a 81.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Rad Laboratories reported $920M in total current liabilities as of March 2026. That compares with $510M in the prior-year period — up 81.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $920M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.

Bio-Rad Laboratories is classified in the Healthcare sector. On total current liabilities, it currently shows $920M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIO with unrelated industries.